-
1
-
-
0000673072
-
Diphenyl-hydantoin metabolism, blood levels and toxicity
-
Kutt, H., Winters, W., Kokenge, R., McDowell, F. Diphenyl-hydantoin metabolism, blood levels and toxicity. Arch Neurol 1964, 11: 642-8.
-
(1964)
Arch Neurol
, vol.11
, pp. 642-648
-
-
Kutt, H.1
Winters, W.2
Kokenge, R.3
McDowell, F.4
-
2
-
-
0006249743
-
Serum diphenylhydantoin (Phenytoin) in ambulant patients with epilepsy
-
Lund, M., Jorgensen, R.S., Kuhl, V. Serum diphenylhydantoin (Phenytoin) in ambulant patients with epilepsy. Epilepsia 1964, (23): 51-8.
-
(1964)
Epilepsia
, Issue.23
, pp. 51-58
-
-
Lund, M.1
Jorgensen, R.S.2
Kuhl, V.3
-
3
-
-
0002214801
-
Absorption and dissolution studies in sodium diphenylhydantoin capsules
-
Arnold, K., Gerber, N., Levy, G. Absorption and dissolution studies in sodium diphenylhydantoin capsules. Can J Pharm Sci 1970, 5: 89-92.
-
(1970)
Can J Pharm Sci
, vol.5
, pp. 89-92
-
-
Arnold, K.1
Gerber, N.2
Levy, G.3
-
4
-
-
0014969990
-
Outbreak of anticonvulsant intoxication in Australian city
-
Tyrer, J., Eadie, M.J., Sutherland, J.M., Hooper, W.D. Outbreak of anticonvulsant intoxication in Australian city. Br Med J 1970, 4: 271-3.
-
(1970)
Br Med J
, vol.4
, pp. 271-273
-
-
Tyrer, J.1
Eadie, M.J.2
Sutherland, J.M.3
Hooper, W.D.4
-
5
-
-
0016734130
-
Chronic anti-epileptic toxicity - A review
-
Reynolds, E.H. Chronic anti-epileptic toxicity-a review. Epilesia 1975, 16: 319-52.
-
(1975)
Epilesia
, vol.16
, pp. 319-352
-
-
Reynolds, E.H.1
-
6
-
-
0029097170
-
Effects of an acidic beverage (Coca-Cola) on the absorption of Ketoconazole
-
Thomas, W.F. Chin., M., Loeb, I., Fong., W. Effects of an acidic beverage (Coca-Cola) on the absorption of Ketoconazole. Antimicrobial Agents Chemother 1995, 39(8): 1671-5.
-
(1995)
Antimicrobial Agents Chemother
, vol.39
, Issue.8
, pp. 1671-1675
-
-
Thomas, W.F.1
Chin, M.2
Loeb, I.3
Fong, W.4
-
7
-
-
0031008645
-
Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole
-
Jaruratanasirikul, S., Kleepkaew., A. Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole. J Clin Pharmacol 1997, 52(3): 235-7.
-
(1997)
J Clin Pharmacol
, vol.52
, Issue.3
, pp. 235-237
-
-
Jaruratanasirikul, S.1
Kleepkaew, A.2
-
8
-
-
1642449373
-
-
th Edition
-
th Edition.
-
-
-
-
9
-
-
0002082298
-
Simultaneous HPLC measurement of Phenobarbitone, Phenytoin and Carbamazepine from plasma samples
-
Joshi, M.V., Pohujani, S.M., Kshirsagar, N.A., Shah, P.H., Acharaya, V.N. Simultaneous HPLC measurement of Phenobarbitone, Phenytoin and Carbamazepine from plasma samples. Ind J Pharmacol 1990, 22: 177-9.
-
(1990)
Ind J Pharmacol
, vol.22
, pp. 177-179
-
-
Joshi, M.V.1
Pohujani, S.M.2
Kshirsagar, N.A.3
Shah, P.H.4
Acharaya, V.N.5
-
10
-
-
0028153858
-
Grapefruit juice and drugs. How significant is interaction?
-
Bailey, D.G., Malcolm, J., Arnold, O., Spence, J.D. Grapefruit juice and drugs. How significant is interaction? Clin Pharmacokinetics 1994, 26: 91-8.
-
(1994)
Clin Pharmacokinetics
, vol.26
, pp. 91-98
-
-
Bailey, D.G.1
Malcolm, J.2
Arnold, O.3
Spence, J.D.4
-
11
-
-
0031657386
-
Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy
-
Garg, S.K., Naresh Kumar., Bhargava, V.K. Prabhakar, S.K. Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. Clin Pharmacol Ther 1998, 64: 286-8.
-
(1998)
Clin Pharmacol Ther
, vol.64
, pp. 286-288
-
-
Garg, S.K.1
Kumar, N.2
Bhargava, V.K.3
Prabhakar, S.K.4
-
12
-
-
0018420581
-
Effect of calcium and antacids on phenytoin bioavailability
-
Chapron, D., Kraner, P.A., Marino, S.L., Hobnadd, D.C. Effect of calcium and antacids on phenytoin bioavailability. Arch Neurol 1979, 36: 936-8.
-
(1979)
Arch Neurol
, vol.36
, pp. 936-938
-
-
Chapron, D.1
Kraner, P.A.2
Marino, S.L.3
Hobnadd, D.C.4
-
13
-
-
0342547065
-
The effect of diet, aging and disease status on presystemic elimination and drug bioavailability in humans
-
Wilkinson, G.R. The effect of diet, aging and disease status on presystemic elimination and drug bioavailability in humans. Adv Drug Deliv Rev 1997, 27: 129-59.
-
(1997)
Adv Drug Deliv Rev
, vol.27
, pp. 129-159
-
-
Wilkinson, G.R.1
|